introduct
coronaviru
intern
public
health
problem
high
rate
sever
clinic
case
sever
treatment
current
test
worldwid
paper
focus
antimalari
drug
chloroquin
hydroxychloroquin
current
review
systemat
studi
good
potenti
candid
report
use
treatment
recent
survey
physician
compar
dynam
daili
death
countri
use
antimalaria
drug
treatment
start
epidem
versu
countri
day
death
follow
day
show
first
group
much
slower
dynam
daili
death
second
group
ecolog
studi
cours
one
addit
piec
evid
debat
regard
effici
antimalaria
drug
also
limit
two
group
certainli
system
differ
way
respond
pandem
way
report
death
popul
better
explain
differ
dynam
systemat
differ
may
also
explain
choic
reli
cortegiani
ingoglia
g
ippolito
giarratano
einav
systemat
review
efficaci
safeti
chloroquin
treatment
journal
critic
care
march
avail
onlin
http
richardson
valeri
hydroxychloroquin
rate
effect
therapi
doctor
coronaviru
global
survey
washington
time
april
avail
onlin
http
q
malaria
drug
first
place
nevertheless
differ
dynam
daili
death
strike
believ
urgenc
context
command
present
result
delv
analysi
end
data
might
ultim
either
piec
evid
favor
antimalaria
drug
step
stone
understand
ecolog
aspect
place
role
dynam
death
studi
set
two
group
countri
studi
dynam
number
death
day
death
follow
day
first
group
made
countri
know
use
produc
chloroquin
hydroxychloroquin
massiv
scale
period
second
group
consist
countri
use
produc
chloroquin
hydroxychloroquin
larg
quantiti
period
consider
calcul
averag
two
group
find
mark
differ
tempor
dynam
see
result
use
box
jenkin
methodolog
appli
arima
auto
regress
integr
move
averag
model
time
seri
compar
model
paramet
obtain
group
countri
make
forecast
mean
two
group
result
unsurprisingli
arima
model
predict
stabil
number
death
group
countri
use
chloroquin
larg
increas
group
countri
use
countri
affect
epidem
term
number
case
studi
one
one
descend
order
determin
whether
conduct
nation
strategi
largescal
use
product
chloroquin
begin
epidem
countri
around
death
evid
strategi
even
sourc
indic
strategi
contrari
countri
classifi
control
group
group
panel
countri
obtain
order
larg
sampl
provid
daili
death
data
avail
day
follow
third
death
second
group
constitut
countri
among
affect
term
number
list
avail
th
april
see
detail
list
annex
http
wwwworldometersinfocoronaviru
countri
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
case
sourc
indic
massiv
use
product
chloroquin
begin
epidem
countri
around
death
provid
daili
death
data
day
follow
death
differ
group
countri
constitut
accord
inform
avail
intern
press
use
mass
product
drug
period
consider
countri
thu
constitut
two
group
see
figur
figur
two
group
number
daili
death
note
day
death
countri
follow
day
averag
daili
death
establish
day
group
countri
group
without
chloroquin
averag
also
calcul
remov
china
anoth
remov
china
spain
two
countri
two
explos
time
seri
may
seen
outlier
trend
chang
substanti
graphic
project
mean
curv
indic
diverg
dynam
daili
death
curv
two
group
countri
clear
period
studi
ie
begin
epidem
see
figur
averag
curv
countri
use
antimalari
drug
rather
stabl
slightli
increas
curv
countri
use
treatment
contrari
strongli
increas
moreov
simpl
regress
curv
clearli
indic
differ
trend
averag
countri
widespread
chloroquin
use
fairli
well
model
slightli
ascend
polynomi
regress
wherea
averag
countri
without
chloroquin
well
model
exponenti
regress
model
forecast
use
arima
auto
regress
integr
move
averag
model
wide
use
time
seri
econometr
introduc
box
jenkin
allow
excel
model
time
seri
base
data
without
includ
theoret
priori
data
therefor
allow
excel
model
intern
dynam
data
highli
predict
tend
valid
relev
wide
use
macroeconom
financ
also
mani
field
biolog
geophys
astronomi
etc
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
let
say
arima
p
q
process
real
correspond
autoregress
coeffici
real
correspond
move
averag
coeffici
order
integr
residu
behav
white
nois
zero
mean
varianc
constant
less
infin
follow
box
jenkin
methodolog
specifi
estim
valid
arima
model
applic
mean
time
seri
two
group
countri
use
r
softwar
give
result
figur
akaik
inform
criterion
aic
model
select
best
rel
altern
model
also
calcul
studi
ie
closest
zero
indic
qualiti
model
specif
criterion
calcul
follow
model
allow
forecast
evolut
death
dynam
two
group
countri
obtain
result
r
first
column
show
number
day
first
day
death
second
column
show
estim
forecast
valu
third
fourth
column
show
low
high
valu
confid
interv
forecast
fifth
sixth
column
show
confid
interv
antimalari
drug
group
see
figur
figur
group
without
chloroquin
see
figur
figur
hyndman
r
et
al
forecast
function
time
seri
linear
model
http
cranrprojectorgwebpackagesforecastforecastpdf
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
forecast
reinforc
earli
visual
observ
group
countri
antimalari
drug
group
forecast
arima
model
indic
stabil
death
curv
control
group
countri
arima
model
forecast
indic
signific
acceler
number
death
note
beyond
acceler
alreadi
visibl
actual
data
mani
countri
statist
avail
valid
model
specif
residu
distribut
test
order
control
behav
white
nois
ie
autocorrel
verif
done
autocorrel
residu
plot
r
autocorrel
function
process
k
order
write
follow
arima
appli
antimalari
drug
group
obtain
autocorrel
figur
autocorrel
signific
residu
behav
white
nois
indic
valid
model
arima
appli
control
group
obtain
autocorrel
figur
way
residu
autocorrel
signific
residu
behav
white
nois
model
specif
estim
valid
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
introduc
box
jenkin
arima
model
socal
atheoret
model
seek
predict
effici
focus
past
data
time
seri
without
worri
caus
past
data
therefor
abl
explain
explanatori
variabl
tempor
evolut
effect
describ
intern
dynam
evolut
instrument
proof
rather
statist
index
updat
dynam
make
possibl
highlight
two
distinct
dynam
first
day
outbreak
use
sinc
highli
contagi
epidem
strong
intern
dynam
alreadi
use
model
spread
epidem
notabl
india
cours
model
claim
model
paramet
explain
tempor
evolut
hand
often
highli
predict
outweigh
mani
model
explanatori
variabl
import
criterion
overal
model
valid
also
note
mani
sourc
exist
determin
health
action
govern
includ
use
mass
product
chloroquin
onset
crisi
quantit
data
lack
allow
indepth
tempor
analys
causal
test
also
might
systemat
differ
two
group
particular
polit
differ
urban
differ
differ
strategi
aspect
test
strong
evid
place
like
south
korea
japan
mass
test
effect
strategi
control
epidem
studi
might
proxi
test
strategi
aspect
examin
late
studi
box
georg
jenkin
gwilym
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
find
major
differ
death
rate
countri
use
antimalari
drug
fare
better
analysi
cours
one
addit
piec
evid
debat
regard
effici
antimalaria
drug
also
limit
two
group
certainli
system
differ
way
respond
pandem
nevertheless
differ
dynam
strike
believ
urgenc
context
command
present
ecolog
studi
delv
analysi
end
data
might
ultim
either
piec
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
annex
list
countri
covid
total
case
th
april
see
note
studi
http
wwwworldometersinfocoronaviru
countri
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
